Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREMYC: Josamycin for Prevention of Preterm Birth
NCT00718705Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2008
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in preterm birth comparing Josamycin Arm with Placebo Arm (2 arms). Primary endpoint: Premature birth. Started Jul 2008; status: completed.
02
Drugs
josamycin
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT00718705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00718705.